A naturalistic cohort study on effectiveness, safety and usage pattern of an over-the-counter nicotine patch: Cohort study on smoking cessation

European Journal of Clinical Pharmacology

Volumn 59, Issue 5-6, 2003, Pages 443-447

  Hasford, Joerg ^a   Fagerstrom, Karl Olov ^b   Haustein, Knut Olav ^c  

^a UNIVERSITY OF MUNICH   (Germany)

^b Fagerstrom Consulting   (Sweden)

^c Institut fur Nikotinforschung   (Germany)

Author keywords

Nicotine patch; Nicotine replacement therapy; Smoking cessation

Indexed keywords

NICOTINE; NON PRESCRIPTION DRUG;

ADULT; ARTICLE; BLISTER; CARDIOTOXICITY; CIGARETTE SMOKING; CLINICAL TRIAL; COHORT ANALYSIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DATA ANALYSIS; DREAMING; DRUG EFFICACY; DRUG SAFETY; DRUG SELF ADMINISTRATION; DRUG USE; DRY SKIN; ERYTHEMA; FEMALE; FUNCTIONAL ASSESSMENT; GASTROINTESTINAL SYMPTOM; HEADACHE; HOSPITAL ADMISSION; HUMAN; INSOMNIA; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; PATIENT COMPLIANCE; PRIORITY JOURNAL; PRURITUS; QUESTIONNAIRE; RASH; SIDE EFFECT; SKIN MANIFESTATION; SLEEP DISORDER; SMOKING; SWEATING; TACHYCARDIA;

ADMINISTRATION, CUTANEOUS; ADULT; COHORT STUDIES; DRUGS, NON-PRESCRIPTION; FEMALE; HUMANS; MALE; MIDDLE AGED; NICOTINE; NICOTINIC AGONISTS; PATIENT COMPLIANCE; QUESTIONNAIRES; SMOKING CESSATION; TIME FACTORS; TREATMENT OUTCOME;

EID: 0141483118     PISSN: 00316970     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00228-003-0629-8     Document Type: Article

References (17)

1. Department of Health and Social Security (1999) Smoking kills - a white paper on tobacco. The Stationary Office, London
2. Silagy C, Lancaster T, Stead L, Mant D, Fowler G (2001) Nicotine replacement therapy for smoking cessation (Cochrane Review). Cochrane Database Syst Rev 3:CD000146
3. Lasagna L (1974) A plea for the "naturalistic" study of medicines. Eur J Clin Pharmacol 7:153-154
4. Heatherton TF, Kozlowski LT, Frecker RC et al (1991) The Fagerström test for nicotine dependence: a revision of the Fagerström Tolerance Questionnaire. Br J Addiction 86:1119-1127
5. Sinclair HK, Bond CM, Hannaford PC (2001) Long term follow-up studies of users of nonprescription medicines purchased from community pharmacies. Drug Safety 24:929-935
6. Orleans CT, Resch N, Noll E, et al (1994) Use of transdermal nicotine in a state-level prescription plan for the elderly: a first look at 'real world' patch users. JAMA 271:601-607
7. Shaw JP, Ferry DG, Damian PB et al (1998) Usage patterns of transdermal nicotine when purchased as a non-prescription medicine from pharmacy. Tob Control 7:161-167
8. Hughes JR (2001) Commentaries on the effectiveness of over-the-counter nicotine replacement. Drugs Alcohol Rev 20:319-324
9. Hays JT, Croghan IT, Schroeder DR et al (1999) Over-the-counter nicotine patch therapy for smoking cessation: results from randomized, double-blind, placebo-controlled, and open label trials. Am J Public Health 89:1701-1707
10. Rumpf H-J, Meyer C, Hapke U, Dilling H, John U (1998) Stadien tier Änderungsbereitschaft bei Rauchern in der Allgemeinbevölkerung. Gesundheitswesen 60:592-597
11. Junge B, Nagel M (1999) Das Rauchverhalten in Deutschland. Gesundheitswesen 61:S121-S125
12. Tonnesen P, Paoletti P, Gustavsson Get al (1999) Higher dosage nicotine patches increase one-year smoking cessation rates: results from the European CEASE trial. Collaborative European Anti-Smoking Evaluation. European Respiratory Society. Eur Respir J 13:238-246
13. Balfour D, Benowitz N, Fagerström K et al (2000) Diagnosis and treatment of nicotine dependence with emphasis on nicotine replacement therapy, a status report. Eur Heart J 21:438-445
14. West R, Hajek P, Foulds J, Nilsson F, May S, Meadows A (2000) A comparison of the abuse liability and dependence potential of nicotine patch, gum, spray and inhaler. Psychopharmacology 149:198-202
15. Gourlay SG, Forbes A, Marriner T et al (1999) Predictors and timing of adverse experiences during transdermal nicotine therapy. Drug Safety 20:545-555
16. Joseph AM, Norman SM, Ferry LH et al (1996) The safety of transdermal nicotine as an aid to smoking cessation in patients with cardiac disease. N Engl J Med 335:1792-1799
17. Kimmel SE, Berlin JA, Miles C et al (2001) Risk of acute first myocardial infarction and use of nicotine patches in a general population. J Am Coll Cardiol 37:1297-1302